NCT00244296

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms of Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 276 (planned)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Female
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine how effective duloxetine is in treating women who are 65 years of age or older with symptoms of stress urinary incontinence, or with a combination of stress urinary incontinence and urge urinary incontinence symptoms.

Conditions

• Urinary Incontinence, Stress

Interventions

Type	Name	Description
DRUG	Duloxetine hydrochloride
DRUG	placebo

Timeline

• Start date: 2005-10-01
• Completion: 2007-01-01
• First posted: 2005-10-26
• Last updated: 2007-01-26

Locations

31 sites across 7 countries: France, Germany, Netherlands, South Africa, Spain, Sweden, Switzerland